Plain-English translation of NCT04080167 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tested two smartphone applications designed to help people with sickle cell disease manage their treatment with hydroxyurea. One app was created for patients to help them remember to take their medication, stay motivated, and understand how the treatment works. The other app was created for doctors to help them prescribe and monitor this medication more effectively.
Hydroxyurea has been proven to reduce pain, complications, and hospital visits for people with sickle cell disease, but many patients and doctors face barriers to using it consistently. This trial was designed to see if smartphone apps could remove those barriers by helping patients stay on track and giving doctors better tools to care for them.
Participants in this trial received one of two smartphone apps to use for several months. If you were assigned to the patient app, you would use the InCharge Health app for 6 months to help you remember and stay motivated to take your hydroxyurea. If your doctor was assigned to receive an app, they would use the HU Toolbox app for 9 months to help them prescribe and monitor your treatment. The trial followed participants over time to see if these apps helped people take their medication more consistently and improved their health outcomes.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States